Krunic Milica, Ertl Reinhard, Hagen Benedikt, Sedlazeck Fritz J, Hofmann-Lehmann Regina, von Haeseler Arndt, Klein Dieter
Center for Integrative Bioinformatics Vienna, Max F. Perutz Laboratories, University of Vienna, Medical University of Vienna, A-1030, Vienna, Austria.
VetCore Facility for Research, University of Veterinary Medicine Vienna, A-1210, Vienna, Austria.
BMC Vet Res. 2015 Apr 10;11:90. doi: 10.1186/s12917-015-0378-9.
Cats infected with exogenous feline leukemia virus (exFeLV) have a higher chance of lymphoma development than uninfected cats. Furthermore, an increased exFeLV transcription has been detected in lymphomas compared to non-malignant tissues. The possible mechanisms of lymphoma development by exFeLV are insertional mutagenesis or persistent stimulation of host immune cells by viral antigens, bringing them at risk for malignant transformation. Vaccination of cats against exFeLV has in recent years decreased the overall infection rate in most countries. Nevertheless, an increasing number of lymphomas have been diagnosed among exFeLV-negative cats. Endogenous feline leukemia virus (enFeLV) is another retrovirus for which transcription has been observed in cat lymphomas. EnFeLV provirus elements are present in the germline of various cat species and share a high sequence similarity with exFeLV but, due to mutations, are incapable of producing infectious viral particles. However, recombination between exFeLV and enFeLV could produce infectious particles.
We examined the FeLV expression in cats that have developed malignant lymphomas and discussed the possible mechanisms that could have induced malignant transformation. For expression analysis we used next-generation RNA-sequencing (RNA-Seq) and for validation reverse transcription quantitative PCR (RT-qPCR). First, we showed that there was no expression of exFeLV in all samples, which eliminates the possibility of recombination between exFeLV and enFeLV. Next, we analyzed the difference in expression of three enFeLV genes between control and lymphoma samples. Our analysis showed an average of 3.40-fold decreased viral expression for the three genes in lymphoma compared to control samples. The results were confirmed by RT-qPCR.
There is a decreased expression of enFeLV genes in lymphomas versus control samples, which contradicts previous observations for the exFeLV. Our results suggest that a persistent stimulation of host immune cells is not an appropriate mechanism responsible for malignant transformation caused by feline endogenous retroviruses.
感染外源性猫白血病病毒(exFeLV)的猫患淋巴瘤的几率高于未感染的猫。此外,与非恶性组织相比,在淋巴瘤中检测到exFeLV转录增加。exFeLV导致淋巴瘤发生的可能机制是插入诱变或病毒抗原对宿主免疫细胞的持续刺激,使它们有发生恶性转化的风险。近年来,在大多数国家,给猫接种exFeLV疫苗已降低了总体感染率。然而,在exFeLV阴性的猫中诊断出的淋巴瘤数量却在增加。内源性猫白血病病毒(enFeLV)是另一种在猫淋巴瘤中观察到有转录现象的逆转录病毒。enFeLV前病毒元件存在于各种猫科动物的种系中,与exFeLV具有高度的序列相似性,但由于突变,无法产生有感染性的病毒颗粒。然而,exFeLV和enFeLV之间的重组可能产生有感染性的颗粒。
我们检测了发生恶性淋巴瘤的猫中FeLV的表达,并讨论了可能诱导恶性转化的机制。对于表达分析,我们使用了下一代RNA测序(RNA-Seq),并通过逆转录定量PCR(RT-qPCR)进行验证。首先,我们表明所有样本中均未检测到exFeLV的表达,这排除了exFeLV与enFeLV之间重组的可能性。接下来,我们分析了对照样本和淋巴瘤样本中三个enFeLV基因表达的差异。我们的分析表明,与对照样本相比,淋巴瘤中这三个基因的病毒表达平均下降了3.40倍。RT-qPCR证实了该结果。
与对照样本相比,淋巴瘤中enFeLV基因的表达降低,这与之前关于exFeLV的观察结果相矛盾。我们的结果表明,宿主免疫细胞的持续刺激不是猫内源性逆转录病毒引起恶性转化的合适机制。